US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 8.200
  • -0.180-2.15%
Trading Aug 28 14:00 ET
401.16MMarket Cap-8631P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
3.69%14.26M
39.22%14.5M
11.84%57.42M
19.91%17.57M
26.04%15.69M
24.43%13.75M
-21.06%10.42M
-7.17%51.35M
-1.99%14.65M
-5.63%12.45M
Operating revenue
3.69%14.26M
39.22%14.5M
11.84%57.42M
19.91%17.57M
26.04%15.69M
24.43%13.75M
-21.06%10.42M
-7.17%51.35M
-1.99%14.65M
-5.63%12.45M
Cost of revenue
Gross profit
Operating expense
-5.90%27.01M
-23.83%25.71M
-15.14%110.72M
-25.79%23.81M
-6.47%24.45M
-7.84%28.7M
-17.86%33.76M
-55.47%130.47M
-39.18%32.08M
-59.80%26.14M
Selling and administrative expenses
-11.53%17.06M
-12.72%16.74M
4.51%70.1M
-7.41%15.49M
-0.83%16.14M
18.84%19.28M
7.52%19.18M
-32.45%67.07M
-22.23%16.73M
-23.58%16.28M
Research and development costs
5.61%9.95M
-38.46%8.97M
-35.92%40.62M
-45.84%8.31M
-15.77%8.31M
-36.85%9.43M
-37.33%14.57M
-67.27%63.39M
-50.85%15.35M
-77.44%9.87M
Operating profit
14.71%-12.75M
51.98%-11.21M
32.64%-53.29M
64.20%-6.24M
36.03%-8.76M
25.59%-14.95M
16.35%-23.34M
66.71%-79.12M
53.88%-17.43M
73.59%-13.69M
Net non-operating interest income expense
-75.00%484K
-66.86%805K
210.94%6.77M
-61.41%1.22M
-2.97%1.18M
538.94%1.94M
196.70%2.43M
129.26%2.18M
276.32%3.17M
152.69%1.21M
Non-operating interest income
-54.95%1.13M
-51.86%1.43M
6.68%9.12M
-50.38%1.85M
-35.24%1.79M
2.62%2.5M
--2.98M
670.51%8.55M
1,001.18%3.72M
--2.76M
Non-operating interest expense
13.38%644K
14.36%629K
-63.10%2.35M
13.27%623K
-60.58%609K
-73.42%568K
-78.11%550K
-25.48%6.37M
-74.26%550K
-32.88%1.55M
Other net income (expense)
-152.44%-2.95M
82.72%-2.74M
0
61.10%-1.17M
83.12%-1.57M
21.20%-15.87M
0
-100.06%-3.54M
Special income (charges)
-152.44%-2.95M
--0
82.72%-2.74M
--0
--0
61.10%-1.17M
83.12%-1.57M
21.20%-15.87M
--0
-100.06%-3.54M
-Less：Restructuring and merger&acquisition
--0
--0
-78.63%2.74M
--0
--0
-61.10%1.17M
-83.12%1.57M
-36.26%12.84M
--0
-71.26%509K
-Less:Impairment of capital assets
--2.95M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
----
----
----
----
----
----
----
--3.03M
--0
--3.03M
Income before tax
-7.29%-15.22M
53.73%-10.4M
46.92%-49.27M
64.82%-5.02M
52.67%-7.58M
37.77%-14.19M
43.42%-22.48M
65.00%-92.82M
75.40%-14.26M
71.35%-16.02M
Income tax
-10.29%1.31M
419.49%1.26M
65,722.22%5.92M
116,566.67%3.49M
1.37M
29,260.00%1.46M
-175.38%-395K
105.96%9K
98.01%-3K
0
Net income
-5.65%-16.53M
47.19%-11.66M
-106.33%-55.19M
17.87%-8.51M
-100.98%-8.95M
-91.00%-15.65M
14.87%-22.09M
537.32%872.13M
67.65%-10.36M
2,696.10%916.63M
Net income continuous Operations
-5.65%-16.53M
47.19%-11.66M
40.54%-55.19M
40.31%-8.51M
44.14%-8.95M
31.36%-15.65M
45.14%-22.09M
64.98%-92.82M
75.34%-14.26M
71.34%-16.02M
Net income discontinuous operations
----
----
--0
--0
--0
----
----
1,369.96%964.96M
-84.90%3.89M
4,427.01%932.65M
Minority interest income
Net income attributable to the parent company
-5.65%-16.53M
47.19%-11.66M
-106.33%-55.19M
17.87%-8.51M
-100.98%-8.95M
-91.00%-15.65M
14.87%-22.09M
537.32%872.13M
67.65%-10.36M
2,696.10%916.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.65%-16.53M
47.19%-11.66M
-106.33%-55.19M
17.87%-8.51M
-100.98%-8.95M
-91.00%-15.65M
14.87%-22.09M
537.32%872.13M
67.65%-10.36M
2,696.10%916.63M
Basic earnings per share
-21.43%-0.34
31.43%-0.24
-108.44%-1
-13.33%-0.17
-101.40%-0.17
-154.55%-0.28
-2.94%-0.35
512.89%11.85
65.12%-0.15
2,629.17%12.14
Diluted earnings per share
-21.43%-0.34
31.43%-0.24
-108.44%-1
-13.33%-0.17
-101.40%-0.17
-154.55%-0.28
-2.94%-0.35
512.89%11.85
65.12%-0.15
2,629.17%12.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 3.69%14.26M39.22%14.5M11.84%57.42M19.91%17.57M26.04%15.69M24.43%13.75M-21.06%10.42M-7.17%51.35M-1.99%14.65M-5.63%12.45M
Operating revenue 3.69%14.26M39.22%14.5M11.84%57.42M19.91%17.57M26.04%15.69M24.43%13.75M-21.06%10.42M-7.17%51.35M-1.99%14.65M-5.63%12.45M
Cost of revenue
Gross profit
Operating expense -5.90%27.01M-23.83%25.71M-15.14%110.72M-25.79%23.81M-6.47%24.45M-7.84%28.7M-17.86%33.76M-55.47%130.47M-39.18%32.08M-59.80%26.14M
Selling and administrative expenses -11.53%17.06M-12.72%16.74M4.51%70.1M-7.41%15.49M-0.83%16.14M18.84%19.28M7.52%19.18M-32.45%67.07M-22.23%16.73M-23.58%16.28M
Research and development costs 5.61%9.95M-38.46%8.97M-35.92%40.62M-45.84%8.31M-15.77%8.31M-36.85%9.43M-37.33%14.57M-67.27%63.39M-50.85%15.35M-77.44%9.87M
Operating profit 14.71%-12.75M51.98%-11.21M32.64%-53.29M64.20%-6.24M36.03%-8.76M25.59%-14.95M16.35%-23.34M66.71%-79.12M53.88%-17.43M73.59%-13.69M
Net non-operating interest income expense -75.00%484K-66.86%805K210.94%6.77M-61.41%1.22M-2.97%1.18M538.94%1.94M196.70%2.43M129.26%2.18M276.32%3.17M152.69%1.21M
Non-operating interest income -54.95%1.13M-51.86%1.43M6.68%9.12M-50.38%1.85M-35.24%1.79M2.62%2.5M--2.98M670.51%8.55M1,001.18%3.72M--2.76M
Non-operating interest expense 13.38%644K14.36%629K-63.10%2.35M13.27%623K-60.58%609K-73.42%568K-78.11%550K-25.48%6.37M-74.26%550K-32.88%1.55M
Other net income (expense) -152.44%-2.95M82.72%-2.74M061.10%-1.17M83.12%-1.57M21.20%-15.87M0-100.06%-3.54M
Special income (charges) -152.44%-2.95M--082.72%-2.74M--0--061.10%-1.17M83.12%-1.57M21.20%-15.87M--0-100.06%-3.54M
-Less：Restructuring and merger&acquisition --0--0-78.63%2.74M--0--0-61.10%1.17M-83.12%1.57M-36.26%12.84M--0-71.26%509K
-Less:Impairment of capital assets --2.95M------------------0----------------
-Less:Other special charges ------------------------------3.03M--0--3.03M
Income before tax -7.29%-15.22M53.73%-10.4M46.92%-49.27M64.82%-5.02M52.67%-7.58M37.77%-14.19M43.42%-22.48M65.00%-92.82M75.40%-14.26M71.35%-16.02M
Income tax -10.29%1.31M419.49%1.26M65,722.22%5.92M116,566.67%3.49M1.37M29,260.00%1.46M-175.38%-395K105.96%9K98.01%-3K0
Net income -5.65%-16.53M47.19%-11.66M-106.33%-55.19M17.87%-8.51M-100.98%-8.95M-91.00%-15.65M14.87%-22.09M537.32%872.13M67.65%-10.36M2,696.10%916.63M
Net income continuous Operations -5.65%-16.53M47.19%-11.66M40.54%-55.19M40.31%-8.51M44.14%-8.95M31.36%-15.65M45.14%-22.09M64.98%-92.82M75.34%-14.26M71.34%-16.02M
Net income discontinuous operations ----------0--0--0--------1,369.96%964.96M-84.90%3.89M4,427.01%932.65M
Minority interest income
Net income attributable to the parent company -5.65%-16.53M47.19%-11.66M-106.33%-55.19M17.87%-8.51M-100.98%-8.95M-91.00%-15.65M14.87%-22.09M537.32%872.13M67.65%-10.36M2,696.10%916.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.65%-16.53M47.19%-11.66M-106.33%-55.19M17.87%-8.51M-100.98%-8.95M-91.00%-15.65M14.87%-22.09M537.32%872.13M67.65%-10.36M2,696.10%916.63M
Basic earnings per share -21.43%-0.3431.43%-0.24-108.44%-1-13.33%-0.17-101.40%-0.17-154.55%-0.28-2.94%-0.35512.89%11.8565.12%-0.152,629.17%12.14
Diluted earnings per share -21.43%-0.3431.43%-0.24-108.44%-1-13.33%-0.17-101.40%-0.17-154.55%-0.28-2.94%-0.35512.89%11.8565.12%-0.152,629.17%12.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg